Evidence map›Paper›PMID 25054566›Full record

ArticleAmerican journal of respiratory and critical care medicine2014

Is previous respiratory disease a risk factor for lung cancer?

Rachel Denholm, Joachim Schüz, Kurt Straif, Isabelle Stücker, Karl-Heinz Jöckel, Darren R Brenner, Sara De Matteis, Paolo Boffetta, Florence Guida, Irene Brüske and 25 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 2 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 2 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta-analysis.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2020
    Pooled it
  3. Type I interferons induced upon respiratory viral infection impair lung metastatic initiation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Kartagener Syndrome Complicated by Middle and Lower Lobar Mucinous Adenocarcinoma in the Left Lung.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Lung cancer risk score for ever and never smokers in China.Cancer communications (London, England) · 2023
    Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 13 countries.

Rachel Denholm1 International Agency for Research on Cancer, Lyon, France.
Joachim Schüz
Kurt Straif
Isabelle Stücker
Karl-Heinz Jöckel
Darren R Brenner
Sara De Matteis
Paolo Boffetta
Florence Guida
Irene Brüske
Heinz-Erich Wichmann
Maria Teresa Landi
Neil Caporaso
Jack Siemiatycki
Wolfgang Ahrens
Hermann Pohlabeln
David Zaridze
John K Field
John McLaughlin
Paul Demers
Neonila Szeszenia-Dabrowska
Jolanta Lissowska
Peter Rudnai
Eleonora Fabianova
Rodica Stanescu Dumitru
Vladimir Bencko
Lenka Foretova
Vladimir Janout
Benjamin Kendzia
Susan Peters
Thomas Behrens
Roel Vermeulen
Thomas Brüning
Hans Kromhout
Ann C Olsson
Centre international de recherche sur le cancer · FRInstitute for Prevention and Occupational Medicine · DELeibniz Institute for Prevention Research and Epidemiology - BIPS · DENational Cancer Institute · USUniversité Paris-Sud · FRAlberta Health Services · CACancer Care Ontario · CACharles University · CZIcahn School of Medicine at Mount Sinai · USKarolinska Institutet · SELunenfeld-Tanenbaum Research Institute · CAMasaryk Memorial Cancer Institute · CZNofer Institute of Occupational Medicine · PLOrszagos Kornyezetegeszsegugyi Intezet · HUPalacký University Olomouc · CZPublic Health Authority of the Slovak Republic · SKRussian Cancer Research Center NN Blokhin · RUThe Maria Sklodowska-Curie National Research Institute of Oncology · PLThe University of Western Australia · AUUniversité de Montréal · CA

Funding

World Health Organization 001
6 · The paper itself

Abstract

rationalePrevious respiratory diseases have been associated with increased risk of lung cancer. Respiratory conditions often co-occur and few studies have investigated multiple conditions simultaneously.

objectivesInvestigate lung cancer risk associated with chronic bronchitis, emphysema, tuberculosis, pneumonia, and asthma.

methodsThe SYNERGY project pooled information on previous respiratory diseases from 12,739 case subjects and 14,945 control subjects from 7 case-control studies conducted in Europe and Canada. Multivariate logistic regression models were used to investigate the relationship between individual diseases adjusting for co-occurring conditions, and patterns of respiratory disease diagnoses and lung cancer. Analyses were stratified by sex, and adjusted for age, center, ever-employed in a high-risk occupation, education, smoking status, cigarette pack-years, and time since quitting smoking. MEASUREMENTS AND MAIN

resultsChronic bronchitis and emphysema were positively associated with lung cancer, after accounting for other respiratory diseases and smoking (e.g., in men: odds ratio [OR], 1.33; 95% confidence interval [CI], 1.20-1.48 and OR, 1.50; 95% CI, 1.21-1.87, respectively). A positive relationship was observed between lung cancer and pneumonia diagnosed 2 years or less before lung cancer (OR, 3.31; 95% CI, 2.33-4.70 for men), but not longer. Co-occurrence of chronic bronchitis and emphysema and/or pneumonia had a stronger positive association with lung cancer than chronic bronchitis "only." Asthma had an inverse association with lung cancer, the association being stronger with an asthma diagnosis 5 years or more before lung cancer compared with shorter.

conclusionsFindings from this large international case-control consortium indicate that after accounting for co-occurring respiratory diseases, chronic bronchitis and emphysema continue to have a positive association with lung cancer.

Indexed as

AsthmaBronchitis, ChronicCanadaCase-Control StudiesEuropeFemaleHumansLogistic ModelsLung NeoplasmsMaleMiddle AgedMultivariate AnalysisOdds RatioPneumoniaPrevalencePulmonary Emphysemacase–control studydata poolingepidemiologic studylung neoplasmpulmonary disease

Identifiers

PMID25054566
PMCPMC4214084
OpenAlexW2167704143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.